Vanina De Verneuil is EVP and General Counsel of Vir Biotechnology, Inc.. Currently has a direct ownership of 79,460 shares of VIR, which is worth approximately $550,657. The most recent transaction as insider was on Feb 26, 2025, when has been sold 7,373 shares (Common Stock) at a price of $9.14 per share, resulting in proceeds of $67,389. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 79.5K
39.47% 3M change
n/a 12M change
Total Value Held $550,657

Vanina de Verneuil Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 26 2025
SELL
Open market or private sale
$67,389 $9.14 p/Share
7,373 Reduced 8.49%
79,460 Common Stock
Feb 24 2025
SELL
Open market or private sale
$48,572 $9.45 p/Share
5,140 Reduced 5.59%
86,833 Common Stock
Feb 22 2025
BUY
Grant, award, or other acquisition
-
35,000 Added 27.56%
91,973 Common Stock
Dec 02 2024
SELL
Open market or private sale
$624 $8.22 p/Share
76 Reduced 0.13%
56,973 Common Stock
Nov 06 2024
SELL
Open market or private sale
$44,453 $10.11 p/Share
4,397 Reduced 7.16%
56,973 Common Stock
Nov 05 2024
SELL
Open market or private sale
$22,226 $9.47 p/Share
2,347 Reduced 3.68%
61,370 Common Stock
Nov 01 2024
SELL
Open market or private sale
$10,101 $7.2 p/Share
1,403 Reduced 2.15%
63,717 Common Stock
VdV

Vanina De Verneuil

EVP and General Counsel
San Francisco, CA

Track Institutional and Insider Activities on VIR

Follow Vir Biotechnology, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VIR shares.

Notify only if

Insider Trading

Get notified when an Vir Biotechnology, Inc. insider buys or sells VIR shares.

Notify only if

News

Receive news related to Vir Biotechnology, Inc.

Track Activities on VIR